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Abstract
Background: Bile acids (BAs) regulate cardiovascular function via diverse mechanisms. Although in both health and disease
serum glycine-conjugated BAs are more abundant than taurine-conjugated BAs, their effects on myogenic tone (MT), a key
determinant of systemic vascular resistance (SVR), have not been examined.
Methodology/Principal Findings: Fourth-order mesenteric arteries (170–250 mm) isolated from Sprague-Dawley rats were
pressurized at 70 mmHg and allowed to develop spontaneous constriction, i.e., MT. Deoxycholylglycine (DCG; 0.1–100 mM),
a glycine-conjugated major secondary BA, induced reversible, concentration-dependent reduction of MT that was similar in
endothelium-intact and -denuded arteries. DCG reduced the myogenic response to stepwise increase in pressure (20 to
100 mmHg). Neither atropine nor the combination of L-NAME (a NOS inhibitor) plus indomethacin altered DCG-mediated
reduction of MT. K
+ channel blockade with glibenclamide (KATP), 4-aminopyradine (KV), BaCl2 (KIR) or tetraethylammonium
(TEA, KCa) were also ineffective. In Fluo-2-loaded arteries, DCG markedly reduced vascular smooth muscle cell (VSM) Ca
2+
fluorescence (,50%). In arteries incubated with DCG, physiological salt solution (PSS) with high Ca
2+ (4 mM) restored
myogenic response. DCG reduced vascular tone and VSM cytoplasmic Ca
2+ responses (,50%) of phenylephrine (PE)- and
Ang II-treated arteries, but did not affect KCl-induced vasoconstriction.
Conclusion: In rat mesenteric resistance arteries DCG reduces pressure- and agonist-induced vasoconstriction and VSM
cytoplasmic Ca
2+ responses, independent of muscarinic receptor, NO or K
+ channel activation. We conclude that BAs alter
vasomotor responses, an effect favoring reduced SVR. These findings are likely pertinent to vascular dysfunction in cirrhosis
and other conditions associated with elevated serum BAs.
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Introduction
Recent investigations expanded the physiological role of BAs
beyond digestion and cholesterol metabolism to thyroid function,
glucose metabolism and obesity [1]. Over the past decade,
emerging evidence suggests that BAs also act as hormones with
vasoactive properties [2]. BAs regulate cardiovascular function
by interacting with plasma membrane receptors (TGR5,
M3R and M2R), Big Ca
2+-activated K
+ channels (BKCa) and
nuclear receptors (FXR, PXR and VDR) [3–10]. They mediate
vasodilation by mechanisms that are highly dependent on the
arterial bed (central vs. peripheral) and type of BA (secondary vs.
primary; amidated vs. unamidated) [11–13]. Moreover, whereas in
vivo infusion of high dose BAs reduces arterial blood pressure [11],
a direct effect on systemic vascular resistance (SVR) has not been
demonstrated. Small arteries (diameter ,200 mm) are primary
determinants of SVR; the arterial myogenic response, defined as
vasoconstriction in response to increases in intraluminal pressure is
critical for establishing SVR [14]. The splanchnic circulation is a
major site of vascular resistance but effects of BAs on myogenic
responses in splanchnic resistance arteries have not been
investigated [15,16].
BAs are amidated with glycine or taurine, thereby increasing
solubility (see detailed reviews of BA metabolism in [2,17]).
Previously, we reported that conjugated BAs interact functionally
with M3 subtype muscarinic receptors (M3R; encoded by CHRM3)
[18]. Molecular modeling suggests that BAs share structural
similarities with acetylcholine (ACh), a muscarinic receptor ligand;
molecular surface structure and charge distribution on the taurine
amide side chain closely resemble electrostatic charge distribution
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32006on ACh [5]. Using rodent aorta, we found that deoxycholyltaurine
(DCT), the taurine conjugate of deoxycholic acid, reduces PE-
induced tension, and in aorta isolated from Chrm3
2/2 mice, this
response to DCT treatment is reduced [12]. A recent study in
cardiomyocytes indicates that cholyltaurine interacts with M2Rt o
mediate negative chronotropic effects [7]. Hence, in cardiovascu-
lar tissue, whereas a functional interaction between muscarinic
receptors and taurine-conjugated BAs has been demonstrated a
similar interaction for glycine-conjugated BAs has not been
investigated.
Elevated serum BAs are proposed mediators of cardiovascular
dysfunction in cirrhosis and intrahepatic cholestasis of pregnancy
[19–22]. In both health and disease serum glycine-conjugated BAs
are more abundant than taurine-conjugated BAs [20,23,24].
While the effects of taurine-conjugated BAs on cardiovascular
function have been evaluated, neither the effects of BAs on MT,
the key determinant of SVR, nor the effects of glycine-conjugated
BAs on agonist-induced vasoconstriction have been examined
[11,25]. Hence, in the present study, we utilized 4
th-order rat
mesenteric arteries to compare the effects of ACh and deoxycho-
lylglycine (DCG), the glycine conjugate of deoxycholic acid on
pressure-induced vascular tone.
Results
Effect of DCG on myogenic tone in rat pressure-
constricted fourth-order mesenteric arteries
To determine the effect of DCG on MT, increasing concen-
trations of DCG were added to pressure-constricted arteries.
At 70 mmHg, spontaneous vasoconstriction, i.e. MT, was
31.8762.29% of passive diameter (P,0.01). DCG induced concen-
tration-dependent (0.1–100 mM) reduction of MT in endothelium-
intact and -denuded preparations (Fig. 1A). In both, endothelium-
intact and -denuded preparations, reduction of MT was readily
reversed by washout (WO, Fig. 1B) with PSS. As a positive
control, we verified that ACh induces concentration-dependent
Figure 1. Effect of DCG and ACh on MT in rat 4
th-order mesenteric arteries. (A) DCG induces concentration-dependent reduction of MT in
endothelium-intact and -denuded arteries. Asterisks indicate significance when compared to the baseline for both preparations. (B) DCG (100 mM)
reduced MT in endothelium-intact and -denuded arteries. This effect was reversed by washing with PSS; (WO-Wash out). Asterisks indicate
significance when compared to DCG (100 mM)-mediated response in respective arterial preparations. (C) ACh induced concentration-dependent
reduction of MT. There was no effect in vehicle-treated arteries. (D) Addition of 10 mM ACh had no effect on endothelium-denuded preparations
while endothelium-intact preparation achieved diameters similar to passive diameter. Asterisks indicate significance when compared to untreated
endothelium-intact arteries. The dashed-line represents passive diameter (PD). PD is the lumen diameter when VSM is completely inactive. (n=4–5
arteries in each group).
doi:10.1371/journal.pone.0032006.g001
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denudation did not alter DCG-mediated reduction of MT (Fig. 1A), it
abolished ACh-induced reduction of MT (Fig. 1D). These data
indicate that in pressurized fourth-order mesentericrat arteries,DCG
and ACh concentration-dependently reduce MT by different
mechanisms. DCG-mediated reduction of MT is reversible and,
unlike ACh, is endothelium-independent. These observations imply
that the effects of DCG are not mediated by interaction with
muscarinic receptors.
Role of muscarinic receptors in DCG-induced reduction
of MT in fourth-order mesenteric arteries
Previous studies of cardiovascular tissues indicate that BAs
interact functionally with M2R and M3R [5,7]. To determine the
role of muscarinic receptors in DCG-induced reduction of MT, we
first determined the expression profile of muscarinic receptor
subtypes in rat fourth-order mesenteric arteries. As shown in
Figure 2A, using PCR with mRNA extracted from rat fourth-
order mesenteric arteries, we found that mRNA for all muscarinic
receptor subtypes is expressed. Since DCG reduced MT in
endothelium-intact and -denuded arteries (Fig.1A), we evaluated
the ability of the nonselective MR blocker, atropine, to inhibit
DCG-induced reversal of MT. As shown in Figures 2B and 2C,
whereas pre-incubation with atropine prevented ACh-mediated
reduction of MT, DCG-mediated reduction of MT was not
altered. To determine the muscarinic receptor subtype(s) respon-
sible for ACh-induced vasodilation, subtype-selective inhibitors
were tested. Pirenzepine (M1R blocker) and methoctramine (M2R
blocker) did not alter ACh-induced reduction of MT (Fig. 2C).
Tropicamide (M3,4R blocker) marginally shifted the ACh response
curve to the right while 4-DAMP (M3R blocker) markedly
attenuated the response (Fig. 2C). However, 4-DAMP had no
effect on myogenic response (Fig. S1). Collectively, these data
indicate that in rat fourth-order mesenteric arteries: 1) mRNA for
all MR subtypes is expressed, 2) DCG-induced reduction of MT is
muscarinic receptor-independent and 3) M3R mediates ligand
(ACh)-induced reduction of MT.
Role of NO and K
+ channels in DCG-induced reduction of
MT in fourth-order mesenteric arteries
NO plays a major role in MT of resistance arteries. Based on the
results in Figure 1A, endothelium-derived NO is unlikely to play a
role in DCG-induced reduction of MT. Nonetheless, NO derived
from nNOS, expressed in VSM or periarterial nerves, remains a
possiblemediator [26]. To exclude this, the effects of DCG and ACh
on MT were determined in arteries incubated with the global NOS
isoform inhibitor, L-NAME. To exclude a role for byproducts of
cyclooxygenase activity, indomethacin (INDO) was used. As shown
in Figure 3A and 3B, both DCG and ACh induced concentration-
dependent reduction of MT in arteries incubated with L-NAME
plus INDO excluding a role for NO and prostaglandins.
Additionally, inhibition of guanylyl cyclase, the NO target in VSM
cells, had no effect on DCG-induced reduction of MT (Fig. S2).
These findings suggested vasodilation via an endothelium-derived
hyperpolarization factor (EDHF)-dependent mechanism.
In resistance arteries, K
+ channels play a major role in EDHF-
dependent responses and VSM cells express all major types of K
+
channels that regulate MT [27–30]. To test for a role of K
+ channel
activation in DCG-mediated reduction of MT, selective inhibitors
of voltage-gated (KV), inward rectifier (KIR), ATP-dependent
(KATP) and Ca
2+-activated K
+ (KCa) channels were used. As shown
in Figure 3C–F, neither 4-AP (KV blocker1 mM), BaCl2 (KIR
blocker, 30 mM), glibenclamide (KATP blocker, 10 mM) nor TEA
(KCa blocker, 10 mM) prevented DCG-induced reduction of MT.
In contrast, TEA attenuated the ACh-induced reduction of MT,
supporting the ACh-stimulated generation of EDHF. Similarly,
charybdotoxin (ChTX 50 nM, IKCa blocker) plus apamin (50 nM,
SKCa blocker) abolished ACh-induced reduction of MT (data not
shown). All experiments were conducted in the presence of
Figure 2. Role of muscarinic receptors in DCG- and ACh-
induced reduction of MT in rat 4
th-order mesenteric arteries.
(A) PCR reveals expression of all muscarinic receptor subtypes (M1R-
M5R). mRNAs were extracted from arteries for 3 rats. PCR products,
obtained using primers shown in Table 1 (first round), were amplified
for 30 cycles with the second-round primers (Table 2). Agarose gel
electrophoresis of PCR products is shown. (B) DCG-induced concentra-
tion-dependent reduction of MT in endothelium-intact and -denuded
arteries preincubated with 1 mM atropine. (C) 1 mM Atropine and
0.1 mM 4-DAMP markedly attenuated ACh-induced reduction of MT.
Asterisks indicate significance when compared to vehicle-treated
arteries. (n=4–5 arteries in each group).
doi:10.1371/journal.pone.0032006.g002
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reduction of MT is independent of VSM K
+ channels whereas
ACh-induced reduction of MT is KCa–dependent.
Based on these findings, we concluded that in small resistance
arteries, DCG reduces MT independent of muscarinic receptor
activation, and NO- or EDHF-induced modulation of K
+ channel
activity. In view of this, we hypothesized that DCG acts by directly
or indirectly activating VSM Ca
2+ entry pathways that generate
and maintain vascular tone [14]. To test this hypothesis, we
evaluated the effect of DCG on myogenic response, KCl- and
agonist-induced vasoconstriction.
Effect of DCG on myogenic response in fourth-order
mesenteric arteries
Increase in transmural pressure induces constriction of resis-
tance arteries, the myogenic response. To test whether DCG can
Figure 3. Role of NO and K
+ channels in DCG- and ACh-induced reduction of MT in rat 4
th-order mesenteric arteries. (A) DCG induced
concentration-dependent reduction of MT in arteries incubated with L-NAME (300 mM) and INDO (10 mM). (B) ACh induced concentration-dependent
reduction of MT in arteries incubated with L-NAME and INDO. (C–F) Addition of 4-aminopyradine (KV blocker, 1 mM), BaCl2 (KIR blocker, 30 mM),
glibenclamide (KATP blocker, 10 mM) or TEA (KCa blocker, 10 mM) had no effect on DCG-mediated reduction of MT. Only TEA attenuated ACh-
mediated reduction of MT; all experiments were conducted in the presence of L-NAME and INDO. Asterisks indicate significance when compared to
vehicle-treated arteries. (n=4–5 arteries in each group).
doi:10.1371/journal.pone.0032006.g003
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PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e32006Figure 4. Effect of DCG on myogenic response. (A–D) Fourth-order rat mesenteric arteries pretreated with vehicle and DCG (1, 10, 100 mM) were
subjected to a series of intraluminal pressure steps between 20 and 100 mmHg and spontaneous tone was allowed to develop until a stable
diameter was achieved (solid lines). The pressure-response was repeated in Ca
2+-free physiological salt solution (PSS) with 3 mM EGTA and 0.01 mM
diltiazem (dashed lines). Asterisks indicate significant differences between the diameters at each pressure step. (E) Summary data. MT was calculated
as the percent difference in diameter observed for Ca
2+-containing vs. Ca
2+-free PSS at each pressure. DCG (10 and 100 mM) prevented development
of MT in small mesenteric arteries. Asterisks indicate significance when compared to vehicle-treated arteries. (n=5–7 arteries in each group).
doi:10.1371/journal.pone.0032006.g004
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arteries were subjected to stepwise increases of intravascular
pressure from 20 to 100 mmHg in 20-mmHg increments in the
presence of vehicle or 1, 10 or 100 mM DCG. In vehicle-treated
arteries, increases in pressure induced a biphasic response
consisting of an increase followed by reduction in diameter
(Fig. 4A). In arteries treated with 1 mM DCG, myogenic response
was similar to vehicle (Fig. 4B). However, with 10 mM DCG, the
myogenic response was blunted (Fig. 4C) and with 100 mM DCG,
it was absent (Fig. 4D). The calculated MT for each pressure
measurement is summarized in Figure 4E. Collectively, these data
indicate that DCG can markedly suppress myogenic contraction of
mesenteric arteries.
Effect of DCG on vascular smooth muscle (VSM) Ca
2+ in
fourth-order mesenteric arteries
To test the hypothesis that DCG acts by inhibiting VSM Ca
2+
signaling, we investigated its effects on intracellular cytoplasmic
Ca
2+ concentration in arteries loaded with Fluo-2. Fluorescence
was measured before and after incubating arteries with 100 mM
DCG for 5 min. As shown in Figure 5, DCG reversibly reduced
VSM Ca
2+ fluorescence to approximately 50% of baseline. These
data support the hypothesis that reduction of cytoplasmic Ca
2+
concentration underlies the ability of DCG to reduce MT.
Role of high-dose Ca
2+on DCG-induced reduction of
myogenic response
We showed above that DCG reduces myogenic response and
VSM Ca
2+ in pressurized arteries. Based on these findings we
hypothesized that raising extracellular Ca
2+ concentration to
promote VSM Ca
2+ entry would prevent DCG-induced reduction
of MT. Myogenic response was determined in the presence of
100 mM DCG with high Ca
2+ (4 mM)-PSS [31]. As shown in
Figure 6A, in high Ca
2+ (4 mM)-PSS, pressure increases induced
an initial increase followed by reduction in diameter, similar to
normal PSS (Fig. 4A). In contrast to the ability of DCG to inhibit
myogenic contraction in PSS (2 mM Ca
2+, see Fig. 4D, 4E), high
extracellular Ca
2+ (4 mM) rendered it much less effective (Fig. 6B).
The calculated MT for luminal pressure increments is summarized
in Figure 6C, wherein the myogenic response in normal PSS is
also reproduced from data in Figure 4. These data support a role
for modification of VSM cytoplasmic Ca
2+ signaling in DCG-
induced reduction of MT.
Effect of DCG on agonist-induced vasoconstriction
To determine its effect on agonist-induced VSM contraction,
DCG was applied following Angiotensin II (ANG II)-, PE- and
KCl-induced vasoconstriction. Arteries with pre-existing MT were
further constricted by ANG II (0.1 mM) an effect reversed by DCG
(Fig. 7A). A representative tracing of DCG-induced reversal of
ANG II effect is shown in Figure 7B. DCG also attenuated PE
(1 mM)-induced vasoconstriction (Fig. 7C). In contrast, DCG did
not alter KCl (80 mM)-induced vasoconstriction (Fig. 7D). These
results indicate that DCG inhibits agonist-induced vasoconstric-
tion, however, it has no effect on depolarization-mediated
vasoconstriction.
Effect of DCG on PE-induced Ca
2+dynamics in
fourth-order mesenteric artery VSM
To test whether DCG can inhibit Ca
2+ signaling that arises
from adrenergic stimulation, we examined its effects in Fluo-2
loaded arteries treated with PE (1 mM). Fluorescence was
measured before and after incubating arteries with 100 mM
DCG for 5 min. As shown in Figure 8A, DCG blunted PE-
induced Ca
2+ signaling. Representative tracings of Ca
2+ fluores-
cence before and after the addition of DCG are shown in
Figure 8B. These data support the conclusion that DCG blunts
adrenergic contraction, at least partially, by interfering with VSM
Ca
2+ signaling.
Discussion
Under isobaric conditions, small resistance arteries develop
partial constriction i.e., MT. These small resistance arteries
constrict when subjected to increasing intraluminal pressure and
dilate when the pressure is reduced, i.e. myogenic response [32].
Myogenic behavior (MT and myogenic response) governs local
blood flow, systemic vascular resistance and blood pressure
[14,33,34]. Hence, pressurized resistance arterial preparations
are of value in the study of vasoactive properties of molecules
pertinent to modulation of SVR [20,22,35,36].
Our study identifies novel BA-mediated effects on vascular tone,
which adds to the expanding profile of vasogenic properties of
BAs. In rat resistance mesenteric arteries our data indicate that
DCG, a glycine-conjugated secondary BA, reduces MT in an
endothelium-independent and reversible manner. Although M3
muscarinic receptors play a dominant role in ACh- and DCT-
[12], they do not contribute to DCG-mediated reduction of MT.
Likewise, DCG-induced reduction of MT is NO- and prostaglan-
din-independent. Although KCa channel activation is important
for ACh-induced reduction of MT, neither KATP,K V,K IR nor
KCa activation plays a role in DCG-induced reduction of MT.
DCG reduces basal and agonist-stimulated VSM intracellular
[Ca
2+], and a high-concentration of extracellular Ca
2+ attenuates
DCG-induced reduction of MT.
BAs interact functionally with muscarinic receptors [4,5].
Previously,we showed that deoxycholyltaurine, the taurine conjugate
of deoxycholic acid, induces vasodilation of PE-contracted rat and
mouse aorta by M3R-dependent mechanisms [12]. A recent report
indicated that in neonatal rat cardiomyocytes, taurocholate, the
taurine conjugate of cholic acid, stimulates negative chronotropic
effects by interaction with M2R; these actions were abolished by
M2R knockdown [7]. Our experiments (Figs. 1 and 2) indicate that
ACh reduces MT by interacting with M3R. Moreover, 4-DAMP,
Figure 5. DCG reduces VSM Ca
2+ in 4
th-order mesenteric
arteries from rats with MT. Ca
2+ fluorescence was measured in
Fluo-2-loaded arteries before and after incubating with DCG 100 mM for
5 minutes. DCG reduced the arterial VSM Ca
2+ fluorescence by ,50%.
(n=3 arteries in each group).
doi:10.1371/journal.pone.0032006.g005
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response (Fig. S1), suggesting that the M3R-mediated responses are
not constitutive and require activation by a ligand. Despite these
findings and PCR verification of mesenteric expression of all
muscarinic receptor subtypes, atropine did not block DCG-
mediated reduction of MT, thereby showing that DCG is not a
MR agonist. We did not examine the interaction of non-conjugated
or taurine-conjugated DCA with MR. However, based our findings
and those previously reported [7,12] we speculate that amidation
may be a determinant of BA interaction with vasoactive signaling
pathways.
In small mesenteric arteries, both eNOS and nNOS contribute
to the NO-mediated regulation of vascular tone [26]. There are
conflicting reports about the role of NO in BA-mediated changes
in vascular tone. In endothelial cell cultures, BAs activate NOS to
generate NO [37,38]. In rat and mouse aorta, DCT-induced
vasodilation was attenuated by L-NAME [12]. In the present
study, endothelial denudation had no effect on DCG-induced
reduction of MT, excluding a role for eNOS. Vascular regulatory
mechanisms are heterogeneous along the first- to fourth-order
mesenteric arterial arcade [27]. Neither L-NAME, a non-selective
NOS inhibitor, nor a combination of PGI2, NO and K
+ channel
blockers altered DCG-induced reduction of MT (Fig. 3C–3F). We
confirmed expression of eNOS and nNOS and excluded a direct
effect on guanyl cyclase by evaluating the effect of DCG in the
presence ODQ (a guanyl cyclase inhibitor); ODQ did not block
DCG-mediated reduction of MT (Fig. S2). These data provide
novel evidence that DCG-induced reduction of MT is indepen-
dent of NO or K
+ channel activation.
VSM cells express various K
+ channels whose activity can
regulate arterial vascular tone. Dopico et al. demonstrated that
selected BAs reversibly activate BKCa [6]. In cerebral arteries,
lithocholic acid-induced, endothelium-independent vasodilation
was blocked by iberiotoxin, a BKCa blocker. In our studies, TEA,
an established non-selective KCa channel blocker [39,40], had no
effect on DCG- but significantly attenuated ACh-induced
reduction of MT (Fig. 3F). Our findings regarding ACh are
consistent with previous observations in small resistance arteries
where EDHF plays a major role in ACh-induced reduction in MT
[27]. However, our data contrast with studies that identify
activation of BKCa as the sole mechanism of BA-induced
vasodilation [13]. Factors that may account for differences
between our findings and those of Bukiya et al [13] include: 1)
use of arterial preparations from different arterial beds; mesenteric
vs. cerebral; 2) use of dihydroxylated vs. monohydroxylated BAs;
and 3) BA amidation – glycine-conjugated vs. native BA.
Discovery of BA-activated receptors including nuclear receptors
such as FXR, VDR and PXR, and TGR5, a GPCR, have
expanded investigations of cardiovascular effects of BAs [3,41–43].
In the current study, we did not evaluate the role of nuclear
receptors as they are transcription factors and therefore, unlikely
to mediate immediate DCG-induced actions. Previously, TGR5
was shown to be expressed in hepatic sinusoidal endothelium that
activates eNOS via cAMP-dependent mechanism [38,44]. Wheth-
er TGR5 is expressed in mesenteric bed is not known, and in the
current study, the lack of TGR5 antagonists prevented us from
evaluating its role in DCG-mediated effects.
In VSM cells, Gq/11-coupled receptors that induce vasocon-
striction also function as membrane stretch sensors [45]. Our data
Figure 6. Effect Ca
2+ (4 mM)-PSS on DCG-induced reduction of
myogenic response. (A, B) To assess myogenic response, rat fourth-
order mesenteric arteries were subjected to a series of intraluminal
pressure steps between 20 and 100 mmHg in Ca
2+(4 mM)-PSS alone or
with 100 mM DCG. Spontaneous tone was allowed to develop until a
stable diameter was achieved (solid line). The pressure-response was
repeated in Ca
2+-free PSS with 3 mM EGTA and 0.01 mM diltiazem
(dashed line). Asterisks indicate significant differences between the
diameters at each pressure step. (C) Summary data. MT was calculated
as the percent difference in diameter observed for Ca
2+ (4 mM)-
containing vs. Ca
2+-free PSS at each pressure. The bottom myogenic
response curve for DCG (100 mM) in normal PSS is derived from Figure 4.
Incubation of arteries with DCG (100 mM) in Ca
2+ (4 mM)-PSS
attenuated the DCG-induced reduction of myogenic response. Asterisks
indicate significant difference in MT for the respective pressure step
when compared to arteries incubated with DCG (100 mM) in normal
PSS. (n=4–7 arteries in each group).
doi:10.1371/journal.pone.0032006.g006
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II)-induced vasoconstriction. Since Gq/11-coupled receptors are
common to pressure- and agonist-induced vasoconstriction, it is
possible that DCG inhibits Gq/11-dependent signaling to reduce
vascular tone. DCG-induced reduction of MT and agonist-
induced vasoconstriction appear to be Ca
2+-dependent. Since
DCG had no effect on high-dose KCl-induced vasoconstriction, it
appears less likely to affect voltage-gated Ca
2+channels. Regulation
of VSM Ca
2+ is complex, involves multiple ion channels and
signaling proteins; knowledge in this area is continuously evolving.
It is possible that DCG-induced inhibition of receptor-mediated
activation of a Ca
2+ entry pathway partially explains isolated DCG
effects on Ang II- and PE- but not KCl-induced constriction. In
future studies it may be appropriate to focus on the role of Ca
2+
channels and Ca
2+ sensitization in DCG-mediated effects on VSM
Ca
2+ and vasodilation.
Serum BA concentration in adult humans is ,3 mM/l [20,36]. In
cirrhosis and obstructive jaundice, serum BA concentration can exceed
.200 mM/l [19,20,36]. While the effects of taurine-conjugated BAs on
vascular tone have been evaluated before, the effects of glycine-
conjugated BAs have not been studied. In both, cirrhosis and
obstructive jaundice, serum levels of glycine-conjugated BAs are elevated
and are in the same range as those tested in this study [20]. We showed
that a glycine-conjugated BA i.e. DCG, reduces pressure- and agonist-
induced vascular tone by reducing VSM Ca
2+. Cirrhosis and
obstructive jaundice are characterized by decreased SVR and altered
vascular tone, respectively [21,46]. Since, small resistance arteries are
important contributors to SVR, our findings may have biological and
clinical importance with regard to hemodynamic changes associated
with cirrhosis and obstructive jaundice. In vivo studies will be required to
determine the effect of glycine-conjugated BAs on SVR.
Materials and Methods
Arterial isolation and cannulation
All experiments were performed according to protocols
approved by the Institutional Animal Use and Care Committee
of the University of Maryland School of Medicine (Protocol No:
Figure 7. Effect of DCG on agonist-induced vasoconstriction. (A) At 70 mmHg, the arteries developed spontaneous vasoconstriction that was
further augmented by adding ANG II (0.1 mM). DCG attenuated ANG II-induced vasoconstriction. (n=5 arteries). (B) An example tracing of the effect
of DCG on ANG II-induced vasoconstriction. (C) At 70 mmHg, the arteries developed spontaneous vasoconstriction that was further augmented by
adding PE (1 mM). DCG attenuated PE-induced vasoconstriction. (n=12 arteries). (D) DCG (100 mM) did not alter 80 mM KCl-induced vasoconstriction.
(n=3 arteries). Asterisks indicate significant differences when compared to ANG II and PE alone.
doi:10.1371/journal.pone.0032006.g007
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with controlled temperature and lighting and allowed free access
to water and a commercial rodent chow. Rats (100 to 150 g) were
anesthetized by intraperitoneal injection of ketamine (80 mg/kg)
and xylazine (10 mg/kg). The abdomen was opened and part of
the distal mesenteric artery arcade was rapidly removed and
transferred to a chamber containing ice-cold dissection solution
containing (mM/l): 3.0 MOPS, 145.0 NaCl, 5.0 KCl, 2.5 CaCl2,
1.0 MgSO4, 1.0 KH2PO4, 0.02 EDTA, 2.0 sodium pyruvate and
5.0 glucose (pH 7.4). Small arteries [passive diameter (PD)=170–
260 mm] parallel to the small intestine, were dissected into 3–5-
mm unbranched segments, cleaned and transferred to a perfusion
chamber. The proximal end of vessels was cannulated with a glass
micropipette (diameter: 100–150 mm), secured with a suture and
blood was gently rinsed from the lumen. The distal end of the
vessels was tied onto a second glass cannula. One cannula was
connected to a servo-controlled pressure-regulating device (Living
Systems; Burlington, VT), and the other to a closed stopcock. The
chamber was transferred to an inverted microscope and the vessel
superfused (4 ml/min) with PSS (mM/l): 112.0 NaCl, 25.7
NaHCO3, 4.9 KCl, 2.0 CaCl2, 1.2 MgSO4, 1.2 KHPO4, 11.5
glucose and 10.0 HEPES (pH 7.4, equilibrated with gas mixture:
5% CO2,5 %O 2 and 90% N) [47]. Intraluminal pressure was
slowly increased from 20 to 100 mmHg and vessels with leaks
were discarded. Subsequently, temperature was raised to 37uC
and arteries were allowed to equilibrate at 70 mmHg (in the
absence of intraluminal flow) to develop MT manifested as ,20%
decrease in diameter. Only arteries that exhibited spontaneous
and stable MT were studied. Vascular viability was confirmed in
all arteries by vasoconstrictor responses to phenylephrine (PE) and
vasodilator responses to ACh. Where required, endothelium was
denuded by passing an air bubble through the arteries. Arteries
were allowed to stabilize for 20–30 min. Denudation was
confirmed by loss of response to ACh.
Diameter measurement
Arteries were viewed with a 106 objective on a Nikon TMS
microscope equipped with a monochrome video charge-coupled
device camera. The luminal diameter was measured by image
capture with a video frame grabber and real-time edge-detection
(Living Systems; Burlington, VT or Ionoptix, Milton, MA). Data
were continuously sampled and recorded with Axoscope software
(Axon Instruments or Ionoptix, Milton, MA). Passive diameter
(PD) was determined at the end of each experiment by incubating
arteries in Ca
2+-free PSS for 20 min.
Calcium fluorescence
In experiments where a Ca
2+ indicator was used, the selected
artery was exposed to dissection solution containing fluo-2
(TEFLabs, 7.5 mM), 1.5% DMSO (vol/vol), and 0.03% cremo-
phor EL (vol/vol) for 1 h at room temperature. After 1 h, the
arteries were cannulated as described above and allowed to
develop MT for 30 min. Arteries were imaged with a confocal
scanning inverted microscope (660, 1.4 NA, water-immersion
objective). Images of fluo-2-loaded fluorescent VSM were obtained
with an intensified CCD camera (Stanford Photonics, Palo Alto,
CA, USA) coupled to a Nipkow spinning disk confocal microscope
with 488 nm excitation. Spatially resolved information on
cytoplasmic [Ca
2+] was obtained in individual VSM cells. To
quantify changes, fluo-2 fluorescence (F) was normalized to its
initial value (F0) in each cell.
Myogenic response
To assess myogenic response, arteries were subjected to
incremental pressures between 20 and 100 mmHg (20, 40, 60,
80 and 100). At each pressure, spontaneous MT was allowed to
develop until a stable diameter was achieved, usually within 5 min.
After completion of the pressure-response curve, intraluminal
pressure was maintained at 20 mmHg, and arteries were
superfused with Ca
2+-free PSS with EGTA 3 mM plus diltiazem
0.01 mM. The pressure-response curve was then repeated to
measure the corresponding passive diameters. MT was calculated
as the percent difference in diameter observed for Ca
2+-containing
versus Ca
2+-free PSS at each pressure.
RNA extraction and quantitative PCR (qPCR)
Small arteries parallel to the small intestine were dissected,
pooled and stored in 1 ml TrizolH Reagent (Invitrogen). RNA was
extracted from tissue homogenates using standard isolation
procedures and stored at 280uC. After DNase treatment for
30 min, RNA was subjected to first strand cDNA synthesis with
random hexamer primers using the ProtoscriptH II RT-PCR kit
Figure 8. Effect of DCG on agonist-mediated changes in VSM
Ca
2+. (A) Fluo-2-loaded arteries were treated with PE 1 mM. Ca
2+
fluorescence was measured before and after incubating with DCG
100 mM for 5 minutes. DCG reduced the arterial VSM Ca
2+ fluorescence
by ,50%. (B) An example of fluorescence tracings from the same artery
before and after addition of DCG is shown (a.u., arbitrary units). (n=5
arteries in each group).
doi:10.1371/journal.pone.0032006.g008
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for 30 cycles using 2xPCR buffer (25 ml), Taq polymerase (1 ml)
and primers (Table 1) designed to amplify the target sequences.
Primers were designed to span an intron and all qPCR products
were of the predicted size. qPCR was carried out in a Perkin
Elmer Gene Amp PCR System 9700 block (Perkin-Elmer,
Norwalk, CT U.S.A). One microliter of autoclaved RNAse- and
DNase-free water was amplified to control for nucleic acid
contamination. After the first-round PCR, the amplified product
(1 ml) was further subjected to nested PCR for 30 cycles using a
second set of primers (Table 2). Control (10 ml) and nested-
reaction products (10 ml) were subjected to electrophoresis on a
1.0% agarose gel containing 0.001% EtBr and visualized by
fluorescent illumination (BioRad, Hercules, CA).
Reagents
DCG and ACh were prepared from stock solution by serial
dilutions into freshly prepared PSS. To test for roles of muscarinic
receptors, arteries were incubated with inhibitors for at least
30 min before adding DCG and ACh. Muscarinic receptor
antagonists included pirenzepine (1 mM, M1R), methoctramine
(1 mM, M2R), 4-DAMP (0.1 mM, M3R), tropicamide (1 mM,
M3,4R) and atropine (1 mM). Experiments to assess non-PGI2 and
non-NO vasodilation were performed by pre-incubating arteries in
indomethacin (INDO, 10 mM) and L-NAME (300 mM) for at least
40 min. Experiments to assess the effects of K
+ channel subtype
blockade employed 4-aminopyridine (4-AP; 1 mM, KV-inhibitor),
BaCl2 (30 mM; KIR-inhibitor), glibenclamide (10 mM; KATP-
inhibitor) and tetraethylammonium (TEA 10 mM; KCa-inhibitor).
All reagents and inhibitors were purchased from Sigma Aldrich.
Data handling and statistical Analysis
DCG and ACh effects were observed for at least 5 min. The
diameter of arteries undergoing vasomotion was calculated by
averaging the plateau phase for 1 min. The data are expressed as
percent of maximal relaxation (%Max) according to the
relationship: %Max=1006 [DDC/DDB]; where DDB is the
difference between PD in Ca
2+-free buffer and basal diameter
and DDc is the difference between diameter in DCG or ACh and
basal diameter.
Myogenic response (MR) is expressed as a percent of PD, and
calculated from the basal diameter as : 1006 (PD–basal
diameter)/PD.
Comparison of means was performed using Student’s t-test (two
groups) or ANOVA (multiple groups) as appropriate. Results are
presented as mean 6 S.E.M. Three to 12 rats were used for each
experimental condition; in the figure legends n represents the
number of arteries examined. Significance was defined as p,0.05
and expressed in illustrations as
*p,0.05,
**p,0.01, and
***p,0.001.
Supporting Information
Figure S1 Effect of 4-DAMP on myogenic response.
Fourth-order rat mesenteric arteries pretreated with vehicle and
0.1 mM 4-DAMP were subjected to a series of intraluminal pressure
stepsbetween 20 and100 mmHgandspontaneoustone was allowed
to develop until a stable diameter was achieved. The pressure-
response was repeated in Ca
2+-free physiological salt solution (PSS)
with 3 mM EGTA and 0.01 mM diltiazem. MT was calculated as
the percent difference in diameter observed for Ca
2+-containing vs.
Ca
2+-free PSS at each pressure. 4-DAMP (0.1 mM), which inhibits
ACh-induced reduction ofMT, had no effect on myogenic response.
(n=4 arteries in each group).
(DOC)
Figure S2 Role of cGMP in DCG-induced reduction of
MT in rat 4
th-order mesenteric arteries. To determine the
role of VSM guanylyl cyclase, a downstream effector of NO, we
examined the effect of ODQ (10 mM), a guanylyl cyclase inhibitor,
on DCG (100 mM)-induced reduction of MT. All experiments
were conducted in the presence of 300 mM L-NAME and 10 mM
INDO. Incubation with ODQ did not alter DCG-mediated
reduction of MT. (n=3 arteries in each group).
(DOC)
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Table 1. First-round PCR Primer Sequences.
Receptor subtype Primer sequence PCR product (bp)
M1R forward gcacaggcacccaccaagcag 373
M1R reverse agagcagcagcaggcggaacg
M2R forward ggcaagcaagagtagaataaa 552
M2R reverse gccaacaggatagccaagatt
M3R forward gtctggcttgggtcatctcct 434
M3R reverse gctgctgctgtggtcttggtc
M4R forward agtgcttcatccagttcttgtcca 588
M4R reverse cacattcattgcctgtctgctttg
M5R forward ctcatcattggcatcttctcca 394
M5R reverse ggtccttggttcgcttctctgt
b-actin forward gtttagaaccttcaacacc 354
b-actin reverse gtggccatcctcttgctcgaagt
bp-base pair.
doi:10.1371/journal.pone.0032006.t001
Table 2. Second-round PCR Primer Sequences.
Receptor subtype Primer sequence PCR product (bp)
M1R forward cctcccaaaagctcccca 331
M1R reverse tgtcccggaaggctttgt
M2R forward gaaggaaaagaaggaacctgt 510
M2R reverse gtcctggtcactttcttttcc
M3R forward cctatgggctcctgccat 388
M3R reverse ttggtccatctgctcggca
M4R forward acccggcagtgacctttg 540
M4R reverse ttacaatttgaatcttggaccat
M5R forward gaacctctacacgacctacatc 350
M5R reverse cccggtagatccggcagtag
b-actin forward aaccgcgagaagatgacccagatcatgttt 333
b-actin reverse agcagccgtggccatcttgctcgaagtc
bp-base pair.
doi:10.1371/journal.pone.0032006.t002
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